Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008729:Methoxamine / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014316:Tritium
D013565:Sympatholytics; D013566:Sympathomimetics; D014316:Tritium; D005934:Glucagon; D011433:Propranolol; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine